IRBS — IR BioSciences Holdings Balance Sheet
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual balance sheet for IR BioSciences Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2006 December 31st | C2007 December 31st | 2008 December 31st | 2009 December 31st | 2010 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 2.75 | 0.221 | 3.16 | 0.28 | 0 |
Prepaid Expenses | |||||
Total Current Assets | 2.83 | 0.308 | 3.38 | 0.349 | 0.045 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.028 | 0.039 | 0.042 | 0.029 | 0.021 |
Other Long Term Assets | |||||
Total Assets | 2.86 | 0.354 | 3.43 | 0.386 | 0.066 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.511 | 0.932 | 2.36 | 3.09 | 6.51 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.511 | 0.932 | 7.66 | 9.4 | 7.4 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 2.35 | -0.58 | -4.23 | -9.02 | -7.34 |
Total Liabilities & Shareholders' Equity | 2.86 | 0.352 | 3.43 | 0.386 | 0.066 |
Total Common Shares Outstanding |